.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Queensland Health
UBS
Medtronic
Healthtrust
Accenture
Chinese Patent Office
Mallinckrodt
Daiichi Sankyo
Express Scripts

Generated: December 15, 2017

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Australia Patent: PP1217

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
Mylan Pharms IncEXTINAketoconazoleAEROSOL, FOAM;TOPICAL021738-001Jun 12, 2007ATRXYesYes► Subscribe► Subscribe► SubscribeYTOPICAL TREATMENT OF SEBORRHEIC DERMATITIS IN IMMUNOCOMPETETENT PATIENTS 12 YEARS OF AGE AND OLDER
Mylan Pharms IncEXTINAketoconazoleAEROSOL, FOAM;TOPICAL021738-001Jun 12, 2007ATRXYesYes► Subscribe► Subscribe► SubscribeYTREATMENT OF SEBORRHEA DERMATITIS IN HUMANS
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist